Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 28% ± 12% | |
peripheral blood | 14 studies | 33% ± 9% | |
kidney | 7 studies | 27% ± 4% | |
eye | 7 studies | 28% ± 11% | |
intestine | 6 studies | 25% ± 12% | |
liver | 6 studies | 27% ± 21% | |
brain | 6 studies | 22% ± 5% | |
lymph node | 5 studies | 27% ± 6% | |
pancreas | 4 studies | 45% ± 19% | |
bone marrow | 4 studies | 20% ± 3% | |
uterus | 4 studies | 31% ± 12% | |
breast | 4 studies | 22% ± 1% | |
placenta | 3 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7969.31 | 1445 / 1445 | 100% | 63.61 | 183 / 183 |
liver | 100% | 4395.92 | 226 / 226 | 100% | 79.04 | 406 / 406 |
ovary | 100% | 5075.67 | 180 / 180 | 100% | 49.20 | 430 / 430 |
skin | 100% | 7842.04 | 1809 / 1809 | 100% | 88.81 | 472 / 472 |
thymus | 100% | 7392.79 | 653 / 653 | 100% | 103.69 | 605 / 605 |
uterus | 100% | 6623.44 | 170 / 170 | 100% | 116.65 | 459 / 459 |
brain | 100% | 7499.18 | 2640 / 2642 | 100% | 103.51 | 705 / 705 |
prostate | 100% | 7811.27 | 245 / 245 | 100% | 98.35 | 501 / 502 |
kidney | 100% | 7441.40 | 89 / 89 | 100% | 72.56 | 898 / 901 |
intestine | 100% | 7304.23 | 966 / 966 | 100% | 68.81 | 525 / 527 |
lung | 100% | 5909.15 | 578 / 578 | 100% | 77.34 | 1150 / 1155 |
adrenal gland | 100% | 7704.03 | 258 / 258 | 100% | 88.88 | 229 / 230 |
stomach | 100% | 5867.93 | 359 / 359 | 99% | 58.89 | 284 / 286 |
bladder | 100% | 7541.71 | 21 / 21 | 99% | 100.21 | 500 / 504 |
breast | 100% | 6742.96 | 459 / 459 | 99% | 97.90 | 1109 / 1118 |
pancreas | 99% | 3544.02 | 324 / 328 | 100% | 82.08 | 178 / 178 |
adipose | 100% | 6773.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 86.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 138.66 | 29 / 29 |
muscle | 100% | 10246.63 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7314.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 117.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 62.48 | 1 / 1 |
blood vessel | 100% | 7371.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5580.69 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 3665.62 | 880 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901800 | Biological process | positive regulation of proteasomal protein catabolic process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000502 | Cellular component | proteasome complex |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0072562 | Cellular component | blood microparticle |
GO_0005829 | Cellular component | cytosol |
GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
GO_0005737 | Cellular component | cytoplasm |
GO_0022624 | Cellular component | proteasome accessory complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0031531 | Molecular function | thyrotropin-releasing hormone receptor binding |
GO_0036402 | Molecular function | proteasome-activating activity |
GO_0140296 | Molecular function | general transcription initiation factor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PSMC5 |
Protein name | 26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG) Proteasome 26S subunit, ATPase 5 26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG) |
Synonyms | SUG1 |
Description | FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC5 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC5 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC5 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC5 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . |
Accessions | J3QRR3 ENST00000703609.1 ENST00000582130.5 A0A994J3X6 ENST00000703611.1 A0A994J6H0 ENST00000584880.6 J3KRP2 J3QSA9 A0A994J6V8 ENST00000703608.1 ENST00000580864.5 [P62195-2] J3QQM1 J3QSE0 ENST00000579708.5 ENST00000310144.11 [P62195-1] J3QRW1 ENST00000585242.5 ENST00000585123.5 P62195 ENST00000584536.5 ENST00000581882.5 [P62195-2] ENST00000584320.5 J3QLH6 ENST00000581842.5 J3KTQ9 ENST00000703610.1 ENST00000375812.8 [P62195-2] |